查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1610269

照护现场- 2025-2030 年全球预测

Point of Care & Rapid Diagnostics Market by Platform (Dipstick, Immunoassay, Microfluidics), Sample (Blood, Urine), Purchase, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，照护现场和快速诊断市场估值为484.3亿美元，预计到2024年将达到518.5亿美元，复合年增长率为7.11%，到2030年将达到783.4亿美元，预计将达到1000万美元。

护理点 (POC) 和快速诊断包括在患者护理点或附近进行的医学测试，并提供快速结果以促进立即临床决策。对此类诊断的需求是由于需要及时诊断以减少患者等待时间并改善结果，特别是在紧急护理、农村地区和大流行期间。 POC 和快速诊断的应用范围从血糖监测和妊娠检测到 COVID-19 等感染疾病的高级分子诊断。最终使用领域包括医院、诊所、居家医疗环境和实验室。市场成长是由技术进步、慢性病盛行率上升以及对医疗服务分散化的需求不断增加所推动的。 COVID-19 大流行显着扩大了对快速检测解决方案的需求，并强调诊断速度是关键因素。机会在于扩大远端医疗、将诊断与数位健康平台整合以及增强即时资料分析以更好地管理患者。然而，与基于实验室的诊断相比，挑战包括先进 POC 设备的高成本、监管限制以及可变的准确性。此外，设备互通性和资料整合等营运问题也阻碍了无缝采用。创新的关键领域包括开发多重测试设备、纳入人工智慧以提高诊断准确性，以及开发携带式、易于使用的家用平台。市场是动态的，反映了向个人化护理和主动健康管理的转变。寻求发展的公司应投资于研发合作，透过具有成本效益的解决方案使其产品组合多样化，并优先对客户进行关于 POC 诊断的好处和正确使用的教育。透过与医疗保健提供者的伙伴关係，扩大准入范围并开拓开拓的地区，我们相信我们可以进一步加强我们的市场占有率并推动永续成长。

主要市场统计
基准年[2023] 484.3亿美元
预测年份 [2024] 518.5亿美元
预测年份 [2030] 783.4亿美元
复合年增长率（%） 7.11%

市场动态：针对快速发展的照护现场和快速诊断市场揭示的关键市场见解

供需的动态交互作用正在改变照护现场和快速诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 感染疾病迅速增加
    • 去中心化医疗保健系统的普及
    • 政府扶持政策
  • 市场限制因素
    • 对新型快速诊断检测的认知较低且缺乏标准监管方法
  • 市场机会
    • 具有多路復用功能的创新 POC 测试
  • 市场挑战
    • 实验室有效诊断方法的替代方法

波特的五力：驾驭照护现场与快速诊断市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解照护现场和快速诊断市场的外部影响

外部宏观环境因素在塑造照护现场和快速诊断市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解照护现场和快速诊断市场的竞争格局

对照护现场和快速诊断市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵照护现场与快速诊断市场供应商绩效评估

FPNV 定位矩阵是评估照护现场和快速诊断市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了照护现场和快速诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，照护现场和快速诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病高发
      • 去中心化医疗保健系统的普及
      • 政府扶持政策
    • 抑制因素
      • 对新型快速诊断检测的认知较低且缺乏标准监管方法
    • 机会
      • 具有多路復用功能的创新 POC 测试
    • 任务
      • 实验室诊断的替代有效方法
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章照护现场和快速诊断市场：按平台

  • 量油尺
  • 免疫检测
  • 微流体

第七章照护现场和快速诊断市场样本

  • 血
  • 尿

第八章照护现场）

  • 在商店
  • 处方笺

第 9 章照护现场和快速诊断市场：按最终用户分类

  • 居家护理
  • 医院
  • 药局

第10章美洲的照护现场与快速诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区照护现场与快速诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的照护现场和快速诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Binx Health, inc.
  • bioMerieux SA
  • Cardinal Health, Inc.
  • Co-Diagnostics, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Genomadix Inc.
  • Lucira Health, Inc.
  • Meridian Bioscience Inc. by SD Biosensor
  • Novartis AG
  • OraSure Technologies, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-742BD5183A2E

The Point of Care & Rapid Diagnostics Market was valued at USD 48.43 billion in 2023, expected to reach USD 51.85 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 78.34 billion by 2030.

Point of Care (POC) and Rapid Diagnostics encompass medical testing conducted at or near the site of patient care, delivering quick results to facilitate immediate clinical decisions. The necessity for such diagnostics stems from the demand for timely diagnosis, especially in emergency care, rural settings, and during pandemics, to reduce patient wait times and improve outcomes. Applications of POC and rapid diagnostics range from glucose monitoring and pregnancy tests to advanced molecular diagnostics for infectious diseases like COVID-19. End-use sectors extend across hospitals, clinics, home care settings, and research laboratories. Market growth is fueled by technological advances, rising prevalence of chronic diseases, and an increasing demand for decentralizing healthcare services. The COVID-19 pandemic significantly expanded the need for rapid testing solutions, highlighting diagnostic speed as a pivotal factor. Opportunities lie in expanding telemedicine and integrating diagnostics with digital health platforms, enhancing real-time data analytics for better patient management. However, limitations such as the high cost of sophisticated POC devices, regulatory constraints, and variable accuracy compared to lab-based diagnostics pose challenges. Additionally, operational issues like device interoperability and data integration also hinder seamless adoption. Key areas for innovation include the development of multi-analyte testing devices, incorporating artificial intelligence for enhanced diagnostic accuracy, and advancing portable, user-friendly platforms for home use. The market is dynamic, reflecting a shift towards personalized care and proactive health management, demanding continuous innovation to address emerging healthcare needs. Companies looking to leverage growth should invest in R&D collaborations, diversify portfolio offerings with cost-effective solutions, and prioritize customer education on benefits and correct usage of POC diagnostics. Expanding access through partnerships with healthcare providers and exploring untapped regions would further cement market presence and drive sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 48.43 billion
Estimated Year [2024] USD 51.85 billion
Forecast Year [2030] USD 78.34 billion
CAGR (%) 7.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High oprevelance of the infectious diseases
    • Proliferation of decentralized healthcare systems
    • Supportive government policies
  • Market Restraints
    • Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
  • Market Opportunities
    • Innovative POC test with multiplexing capabilities
  • Market Challenges
    • Alternate effective ways of diagnosis in laboratories

Porter's Five Forces: A Strategic Tool for Navigating the Point of Care & Rapid Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point of Care & Rapid Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point of Care & Rapid Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point of Care & Rapid Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point of Care & Rapid Diagnostics Market

A detailed market share analysis in the Point of Care & Rapid Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point of Care & Rapid Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point of Care & Rapid Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point of Care & Rapid Diagnostics Market

A strategic analysis of the Point of Care & Rapid Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point of Care & Rapid Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, inc., bioMerieux SA, Cardinal Health, Inc., Co-Diagnostics, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Genomadix Inc., Lucira Health, Inc., Meridian Bioscience Inc. by SD Biosensor, Novartis AG, OraSure Technologies, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Point of Care & Rapid Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Platform, market is studied across Dipstick, Immunoassay, and Microfluidics.
  • Based on Sample, market is studied across Blood and Urine.
  • Based on Purchase, market is studied across OTC and Prescription.
  • Based on End-User, market is studied across Homecare, Hospital, and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High oprevelance of the infectious diseases
      • 5.1.1.2. Proliferation of decentralized healthcare systems
      • 5.1.1.3. Supportive government policies
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative POC test with multiplexing capabilities
    • 5.1.4. Challenges
      • 5.1.4.1. Alternate effective ways of diagnosis in laboratories
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Point of Care & Rapid Diagnostics Market, by Platform

  • 6.1. Introduction
  • 6.2. Dipstick
  • 6.3. Immunoassay
  • 6.4. Microfluidics

7. Point of Care & Rapid Diagnostics Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Urine

8. Point of Care & Rapid Diagnostics Market, by Purchase

  • 8.1. Introduction
  • 8.2. OTC
  • 8.3. Prescription

9. Point of Care & Rapid Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospital
  • 9.4. Pharmacy

10. Americas Point of Care & Rapid Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Point of Care & Rapid Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Point of Care & Rapid Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Binx Health, inc.
  • 4. bioMerieux SA
  • 5. Cardinal Health, Inc.
  • 6. Co-Diagnostics, Inc.
  • 7. Danaher Corporation
  • 8. F. Hoffmann-La Roche AG
  • 9. Genomadix Inc.
  • 10. Lucira Health, Inc.
  • 11. Meridian Bioscience Inc. by SD Biosensor
  • 12. Novartis AG
  • 13. OraSure Technologies, Inc.
  • 14. Siemens Healthineers AG
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIPSTICK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023